Analysts Mayank Mamtani, William Wood, and Brandon Carney said that amid an ongoing innovation wave within central nervous system therapeutics, Denali stands out based on its proprietary blood-brain barrier (BBB) shuttling platform approaches, which enables the safe, efficient, and effective delivery of complex large and small molecules.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,